What question did this study set out to answer?

This research aims to explore macrophage necroptosis as a therapeutic and diagnostic target in atherosclerosis.

July 1, 2016Science AdvancesOpen Access

Targeting macrophage necroptosis for therapeutic and diagnostic interventions in atherosclerosis

View Full Paper

Ask AI

Bookmark

Authors

Randomized trial investigates macrophage necroptosis and its potential in atherosclerosis management, indicating new therapeutic avenues.

This research aims to explore macrophage necroptosis as a therapeutic and diagnostic target in atherosclerosis.
Investigated necroptotic markers RIP3 and MLKL in human atherosclerotic plaques.
Utilized necrostatin-1 as a radiotracer for imaging and analysis in Apoe (-/-) mice.
Assessed the impact of Nec-1 treatment on lesion size and instability markers in atherogenic models.
Increased RIP3 and MLKL expression observed in humans with unstable carotid atherosclerosis.
Necrostatin-1 uptake correlated with atherosclerotic plaque area (p<0.05).
Nec-1 treatment led to reduced lesion size and necrotic core formation in treated mice.

Karunakaran et al. (2016) studied this question.

View Full Paper

Ask AI

Bookmark